U.S. pharma big copyright scrapped two experimental weight loss supplements past 12 months—a once-day by day tablet, lotiglipron, as a result of elevated liver enzymes along with a twice-each day pill, danuglipron, due to solid Uncomfortable side effects—but CEO Albert Bourla has exp